ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,676Medicare Part D Prescriptions Filled, Including Refills

Rank: 35 out of 670

$938K Total Retail Price of All Prescriptions

Rank: 45 out of 670

443 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
57% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 443 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

22% of this provider’s 443 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

3% of this provider’s 11,007 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
SIMVASTATIN 645 410 1 4
HYDROCODONE-ACETAMINOPHEN 552 303 S3 2 1
FUROSEMIDE 540 376 3 6
LEVOTHYROXINE SODIUM 521 391 4 2
ENALAPRIL MALEATE 434 316 5 49
METFORMIN HCL 427 283 6 8
HYDROCHLOROTHIAZIDE 346 265 7 10
METOPROLOL TARTRATE 342 247 8 9
GLIMEPIRIDE 313 190 9 32
OMEPRAZOLE 290 215 10 5
PRAVASTATIN SODIUM 279 213 11 19
ATENOLOL 266 194 12 17
POTASSIUM CHLORIDE 256 219 13 16
TRAMADOL HCL 232 164 14 21
NEXIUM 226 130 15 14
TRICOR 210 132 16 83
ZOLPIDEM TARTRATE 209 97 17 23
METOCLOPRAMIDE HCL 189 98 18 117
CIPROFLOXACIN HCL 171 99 19 60
LISINOPRIL 165 126 20 3
ATORVASTATIN CALCIUM 164 115 21 15
MELOXICAM 160 102 22 33
AMLODIPINE BESYLATE 155 135 23 7
ISOSORBIDE MONONITRATE ER 154 98 24 45
NATEGLINIDE 152 122 25 267
ACETAMINOPHEN-CODEINE 150 100 S3 26 119
GABAPENTIN 145 69 27 11
CRESTOR 142 85 28 18
PROAIR HFA 138 52 29 28
WARFARIN SODIUM 132 99 30 13
CEPHALEXIN 118 77 31 102
CAPTOPRIL 116 94 32 278
AZITHROMYCIN 115 74 33 35
CYCLOBENZAPRINE HCL 111 62 R 34 61
MECLIZINE HCL 110 107 35 114
DIOVAN HCT 105 89 36 126
CARVEDILOL 105 77 36 29
CITALOPRAM HBR 103 39 38 20
CLOPIDOGREL 100 49 39 24
SINGULAIR 98 70 40 56
SULINDAC 97 57 41 217
RAMIPRIL 93 81 42 115
ALENDRONATE SODIUM 92 69 43 43
IBUPROFEN 92 55 43 50
ENALAPRIL-HYDROCHLOROTHIAZIDE 91 44 45 237
FLUCONAZOLE 90 45 46 140
PROMETHAZINE HCL 90 40 R 46 106
RANITIDINE HCL 90 42 46 25
SERTRALINE HCL 89 46 49 22
NIASPAN 87 56 50 116
BUMETANIDE 84 63 51 212
DIOVAN 82 49 52 48
ALLOPURINOL 81 71 53 38
METHOCARBAMOL 81 49 R 53 168
WELCHOL 81 61 53 230
METOPROLOL SUCCINATE 78 63 56 12
LANSOPRAZOLE 77 38 57 86
SUCRALFATE 76 45 58 185
BENICAR HCT 70 61 59 190
BUSPIRONE HCL 69 43 60 124
PHENYTOIN SODIUM EXTENDED 69 50 60 135
LOSARTAN POTASSIUM 68 56 62 26
ROPINIROLE HCL 67 53 63 75
QUINAPRIL HCL 67 56 63 103
MONTELUKAST SODIUM 67 38 63 96
FENOFIBRATE 65 36 66 64
DIGOXIN 64 55 67 46
JANUVIA 64 36 67 53
LANTUS 63 37 69 58
TORSEMIDE 62 46 70 100
DEXILANT 60 19 71 70
INDAPAMIDE 60 60 71 273
OXYCODONE-ACETAMINOPHEN 59 37 S2 73 77
FAMOTIDINE 58 34 74 99
PLAVIX 57 29 75 34
LOSARTAN-HYDROCHLOROTHIAZIDE 56 36 76 73
LYRICA 56 19 76 65
MUPIROCIN 56 37 76 203
PANTOPRAZOLE SODIUM 53 32 79 41
PREMARIN 53 40 R 79 184
CLOTRIMAZOLE-BETAMETHASONE 51 35 81 224
ZETIA 50 29 82 66
ALPRAZOLAM 50 49 82 138
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 7, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.